drugset / Trial / NCT01387711
PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology
NaSingle-groupOpen-labelOther
Summary
This trial will be conducted to explore the biological effects in the skin following treatment with PEP005 Gel, 0.05% administered for two consecutive days, assessed by histology.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ingenol mebutate | Small molecule | 0.05 % | Topical |